Works matching IS 10837159 AND DT 2015 AND VI 20 AND IP 8
Results: 22
In Reply.
- Published in:
- Oncologist, 2015, v. 20, n. 8, p. e25, doi. 10.1634/theoncologist.2015-0157
- By:
- Publication type:
- Article
Long Noncoding RNA in Digestive Tract Cancers: Function, Mechanism, and Potential Biomarker.
- Published in:
- Oncologist, 2015, v. 20, n. 8, p. 898, doi. 10.1634/theoncologist.2014-0475
- By:
- Publication type:
- Article
Hyperthermic Intraperitoneal Chemotherapy Following Cytoreductive Surgery Improves Outcome in Patients With Primary Appendiceal Mucinous Adenocarcinoma: A Pooled Analysis From Three Tertiary Care Centers.
- Published in:
- Oncologist, 2015, v. 20, n. 8, p. 907, doi. 10.1634/theoncologist.2014-0294
- By:
- Publication type:
- Article
Diastolic Dysfunction Following Anthracycline-Based Chemotherapy in Breast Cancer Patients: Incidence and Predictors.
- Published in:
- Oncologist, 2015, v. 20, n. 8, p. 864, doi. 10.1634/theoncologist.2014-0500
- By:
- Publication type:
- Article
Real-Life Use and Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer Patients: A Study of the Southeast Netherlands Breast Cancer Consortium.
- Published in:
- Oncologist, 2015, v. 20, n. 8, p. 856, doi. 10.1634/theoncologist.2015-0006
- By:
- Publication type:
- Article
Therapeutic Effects of Repurposed Therapies in Non-Small Cell Lung Cancer: What Is Old Is New Again.
- Published in:
- Oncologist, 2015, v. 20, n. 8, p. 934, doi. 10.1634/theoncologist.2015-0064
- By:
- Publication type:
- Article
Next-Generation Sequencing and Immunohistochemistry as Future Gold Standard of ALK Testing in Lung Cancer?
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
U.S. Food and Drug Administration Approval Summary: Enzalutamide for the Treatment of Patients With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Oncologist, 2015, v. 20, n. 8, p. 960, doi. 10.1634/theoncologist.2015-0166
- By:
- Publication type:
- Article
Confronting Therapeutic Failure: A Conversation Guide.
- Published in:
- Oncologist, 2015, v. 20, n. 8, p. 946, doi. 10.1634/theoncologist.2015-0050
- By:
- Publication type:
- Article
Imaging in Lymphoma: The Key Role of Fluorodeoxyglucose-Positron Emission Tomography.
- Published in:
- Oncologist, 2015, v. 20, n. 8, p. 890, doi. 10.1634/theoncologist.2015-0036
- By:
- Publication type:
- Article
Phase I/II Study of Weekly Oraxol for the Second-Line Treatment of Patients With Metastatic or Recurrent Gastric Cancer.
- Published in:
- Oncologist, 2015, v. 20, n. 8, p. 896, doi. 10.1634/theoncologist.2015-0202
- By:
- Publication type:
- Article
Changing the Paradigm--Multistage Multiarm Randomized Trials and Stratified Cancer Medicine.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Chemoimmunotherapy for Mucosa-Associated Lymphoid Tissue-Type Lymphoma: A Review of the Literature.
- Published in:
- Oncologist, 2015, v. 20, n. 8, p. 915, doi. 10.1634/theoncologist.2015-0109
- By:
- Publication type:
- Article
Prospective Clinical Utility Study of the Use of the 21-Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor-Positive Early Invasive Breast Cancer: Results From the SWITCH Study.
- Published in:
- Oncologist, 2015, v. 20, n. 8, p. 873, doi. 10.1634/theoncologist.2014-0467
- By:
- Publication type:
- Article
Ponatinib: Accelerated Disapproval.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Phase I/II Trial of Imatinib and Bevacizumab in Patients With Advanced Melanoma and Other Advanced Cancers.
- Published in:
- Oncologist, 2015, v. 20, n. 8, p. 952, doi. 10.1634/theoncologist.2015-0108
- By:
- Publication type:
- Article
Patterns of Care and Clinical Outcomes of First-Line Trastuzumab-Based Therapy in HER2-Positive Metastatic Breast Cancer Patients Relapsing After (Neo)Adjuvant Trastuzumab: An Italian Multicenter Retrospective Cohort Study.
- Published in:
- Oncologist, 2015, v. 20, n. 8, p. 880, doi. 10.1634/theoncologist.2015-0020
- By:
- Publication type:
- Article
Acknowledging the Limitations of Treatment: Surrendering to Reality.
- Published in:
- 2015
- By:
- Publication type:
- Opinion
Breakthrough Drugs and Turtle Soup.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Giving Bad News.
- Published in:
- 2015
- By:
- Publication type:
- Opinion
Nutritional Status, Body Surface, and Low Lean Body Mass/Body Mass Index Are Related to Dose Reduction and Severe Gastrointestinal Toxicity Induced by Afatinib in Patients With Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2015, v. 20, n. 8, p. 967, doi. 10.1634/theoncologist.2015-0058
- By:
- Publication type:
- Article
Metabolic Characteristics of Advanced Biliary Tract Cancer Using <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography and Their Clinical Implications.
- Published in:
- Oncologist, 2015, v. 20, n. 8, p. 926, doi. 10.1634/theoncologist.2014-0356
- By:
- Publication type:
- Article